X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (61423) 61423
Newsletter (12767) 12767
Book Review (7293) 7293
Publication (3329) 3329
Conference Proceeding (533) 533
Newspaper Article (532) 532
Transcript (141) 141
Book Chapter (108) 108
Magazine Article (65) 65
Dissertation (55) 55
Book / eBook (16) 16
Web Resource (11) 11
Trade Publication Article (8) 8
Paper (3) 3
Data Set (2) 2
Journal / eJournal (1) 1
Presentation (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (49306) 49306
index medicus (47888) 47888
lung cancer, non-small cell (31115) 31115
oncology (27435) 27435
male (27190) 27190
female (27127) 27127
lung neoplasms - pathology (23422) 23422
cancer (23318) 23318
middle aged (23203) 23203
aged (22272) 22272
carcinoma, non-small-cell lung - pathology (21536) 21536
carcinoma, non-small-cell lung - drug therapy (18056) 18056
lung cancer (17555) 17555
lung neoplasms - drug therapy (17452) 17452
research (15209) 15209
adult (14049) 14049
care and treatment (13194) 13194
chemotherapy (12875) 12875
prognosis (12192) 12192
carcinoma, non-small-cell lung - genetics (11309) 11309
non-small cell lung cancer (11061) 11061
lung neoplasms - genetics (11038) 11038
neoplasm staging (10853) 10853
oncology, experimental (9662) 9662
aged, 80 and over (9185) 9185
lung neoplasms - mortality (9137) 9137
respiratory system (9093) 9093
carcinoma, non-small-cell lung - mortality (9047) 9047
treatment outcome (7746) 7746
lung neoplasms - metabolism (7649) 7649
carcinoma, non-small-cell lung - metabolism (7594) 7594
carcinoma (7236) 7236
carcinoma, non-small-cell lung - surgery (7204) 7204
lung neoplasms - surgery (7199) 7199
survival (7177) 7177
metastasis (6968) 6968
antineoplastic combined chemotherapy protocols - therapeutic use (6621) 6621
tumors (6586) 6586
analysis (6584) 6584
surgery (6141) 6141
cell line, tumor (6038) 6038
genetic aspects (5945) 5945
retrospective studies (5922) 5922
expression (5474) 5474
survival rate (5472) 5472
mutation (5434) 5434
lung cancer, small cell (5330) 5330
radiotherapy (5167) 5167
antineoplastic agents - therapeutic use (5042) 5042
apoptosis (5000) 5000
animals (4954) 4954
carcinoma, non-small-cell lung - radiotherapy (4847) 4847
survival analysis (4729) 4729
carcinoma, non-small-cell lung - therapy (4712) 4712
lung neoplasms - radiotherapy (4671) 4671
lung neoplasms - therapy (4671) 4671
adenocarcinoma (4375) 4375
health aspects (4355) 4355
nsclc (4327) 4327
non-small cell lung carcinoma (4226) 4226
abridged index medicus (4165) 4165
hematology, oncology and palliative medicine (4165) 4165
gefitinib (4035) 4035
carcinoma, non-small-cell lung - diagnosis (3877) 3877
immunohistochemistry (3863) 3863
lung neoplasms - diagnosis (3858) 3858
reports (3787) 3787
universities and colleges (3657) 3657
cisplatin (3639) 3639
therapy (3531) 3531
development and progression (3495) 3495
non-small-cell lung cancer (3420) 3420
mice (3412) 3412
gene expression (3365) 3365
disease-free survival (3351) 3351
follow-up studies (3302) 3302
cancer therapies (3294) 3294
patients (3274) 3274
carcinoma, non-small-cell lung - secondary (3242) 3242
cell lung-cancer (3194) 3194
medical research (3180) 3180
combined modality therapy (3154) 3154
receptor, epidermal growth factor - genetics (3131) 3131
carcinoma, non-small-cell lung - diagnostic imaging (3055) 3055
diagnosis (3055) 3055
radiology, nuclear medicine & medical imaging (3049) 3049
lung neoplasms - diagnostic imaging (3028) 3028
risk factors (3001) 3001
antineoplastic agents (2996) 2996
epidermal growth factor (2920) 2920
gene expression regulation, neoplastic (2918) 2918
adenocarcinoma - pathology (2894) 2894
respiratory tract diseases (2859) 2859
antimitotic agents (2844) 2844
proteins (2818) 2818
cisplatin - administration & dosage (2806) 2806
medicine & public health (2804) 2804
communicable diseases (2755) 2755
breast-cancer (2695) 2695
erlotinib (2671) 2671
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (69887) 69887
Chinese (1569) 1569
French (1006) 1006
Japanese (879) 879
German (600) 600
Spanish (237) 237
Polish (162) 162
Russian (153) 153
Korean (148) 148
Italian (145) 145
Turkish (77) 77
Portuguese (59) 59
Czech (52) 52
Dutch (42) 42
Hungarian (42) 42
Bulgarian (17) 17
Danish (16) 16
Romanian (16) 16
Serbian (13) 13
Croatian (9) 9
Finnish (8) 8
Hebrew (8) 8
Slovak (7) 7
Icelandic (6) 6
Lithuanian (6) 6
Norwegian (6) 6
Swedish (5) 5
Bosnian (3) 3
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, pp. e96765 - e96765
Non-small cell lung cancers (NSCLCs) cause high mortality worldwide, and the cancer progression can be activated by several genetic events causing receptor... 
MIGRATION | TARGET | GROWTH-FACTOR RECEPTOR | SIGNALING PATHWAYS | MALIGNANCY | CANCER CELLS | MULTIDISCIPLINARY SCIENCES | PROSTATE-CANCER | MIR-133A | PROLIFERATION | EXPRESSION | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Oncogene Proteins - genetics | Cell Proliferation | Prognosis | Carcinoma, Non-Small-Cell Lung - genetics | Neoplasm Invasiveness | Humans | Lung Neoplasms - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Lung Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - diagnosis | Signal Transduction - genetics | Down-Regulation - genetics | Gene Knockdown Techniques | Neoplasm Metastasis | Cell Line, Tumor | MicroRNAs - genetics | Lung Neoplasms - diagnosis | Proto-Oncogene Proteins c-akt - metabolism | Receptors, Cell Surface - genetics | Bone morphogenetic proteins | MicroRNA | B cells | Lung cancer, Non-small cell | Transforming growth factors | Health aspects | Biotechnology | Regulators | Epithelial cells | Transforming growth factor-b | Lung cancer | Lung | AKT protein | Insulin-like growth factors | Metastasis | Kinases | Cancer therapies | Metastases | Receptors | Epidermal growth factor | Rodents | Cell cycle | Life sciences | Heart diseases | Small cell lung carcinoma | Internal medicine | Epidermal growth factor receptors | Invasiveness | MiRNA | Non-small cell lung carcinoma | Lung carcinoma | Tumor cell lines | Ribonucleic acid--RNA | Insulin | Myogenesis | Medicine | Gene silencing | Signaling | Chemotherapy | Correlation analysis | MicroRNAs | Cell lines | Tumor suppressor genes | Mutation | Non-coding RNA | Prostate cancer | Tumors | Cancer | Index Medicus | RNA | Ribonucleic acid
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2012, Volume 7, Issue 10, pp. e46539 - e46539
Splicing abnormalities frequently occur in cancer. A key role as splice site choice regulator is played by the members of the SR (Ser/Arg-rich) family of... 
APOPTOSIS | SC35 | MULTIDISCIPLINARY SCIENCES | SR PROTEINS | KINASE | E2F1 | PROLIFERATION | SF2/ASF | RON PROTOONCOGENE | HISTOLOGY | CANCER | RNA-Binding Proteins - genetics | Adenocarcinoma - pathology | Paclitaxel - pharmacology | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Lung Neoplasms - metabolism | Middle Aged | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Lung Neoplasms - pathology | Male | Phosphoproteins - metabolism | Adenocarcinoma - metabolism | Female | Ribonucleoproteins - genetics | Antineoplastic Agents - pharmacology | Lung - metabolism | Nuclear Proteins - genetics | Protein-Serine-Threonine Kinases - metabolism | Carcinoma, Non-Small-Cell Lung - pathology | Gene Expression | Signal Transduction | Carcinoma, Non-Small-Cell Lung - metabolism | Protein-Serine-Threonine Kinases - genetics | Nuclear Proteins - metabolism | Ribonucleoproteins - metabolism | Phosphoproteins - genetics | Phenotype | Serine-Arginine Splicing Factors | Cell Line, Tumor | Aged | Carboplatin - pharmacology | Neoplasm Staging | RNA-Binding Proteins - metabolism | Immunohistochemistry | Fibronectins | Messenger RNA | Carcinoma | Stem cells | Lung cancer, Non-small cell | Cancer | Adenocarcinoma | Vimentin | Biotechnology | Regulators | Deregulation | Phosphorylation | Mesenchyme | Epithelial cells | Lung | Lung cancer | AKT protein | mRNA | Kinases | E-cadherin | Fibronectin | Proteins | Cell growth | Tumorigenesis | Small cell lung carcinoma | Splicing | Invasiveness | Abnormalities | Agar | Histology | Lung carcinoma | Tumor cell lines | Gene expression | Cisplatin | 1-Phosphatidylinositol 3-kinase | Signaling | Correlation analysis | Cell lines | Tumors | Apoptosis | Index Medicus
Journal Article
Journal Article
CANCER RESEARCH, ISSN 0008-5472, 07/2017, Volume 77, Issue 13, pp. 3540 - 3550
Antibody targeting of the immune checkpoint receptor PD1 produces therapeutic activity in a variety of solid tumors, but most patients exhibit partial or... 
BREAST-CANCER | BIOMARKERS | ANTI-PD-1 THERAPY | PEMBROLIZUMAB | ONCOLOGY | CLINICAL ONCOLOGY/COLLEGE | RECOMMENDATIONS | SENSITIVITY | MECHANISMS | TUMORS | AMERICAN SOCIETY | Gene Expression - drug effects | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Squamous Cell Carcinoma of Head and Neck | Melanoma - genetics | Gene Expression - immunology | Aged, 80 and over | Adult | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Non-Small-Cell Lung - genetics | Head and Neck Neoplasms - drug therapy | Gene Expression Profiling - methods | Melanoma - pathology | Head and Neck Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - immunology | Lung Neoplasms - immunology | Carcinoma, Squamous Cell - drug therapy | Melanoma - immunology | Melanoma - drug therapy | Nivolumab | Head and Neck Neoplasms - genetics | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Programmed Cell Death 1 Receptor - immunology | Programmed Cell Death 1 Receptor - genetics | PD-1 protein | CD8 antigen | Lung | Antibodies | Activation | Lymphocytes T | Killer cells | Cell activation | Lymphocytes | Bioindicators | Neck | Natural killer cells | Signatures | Squamous cell carcinoma | Head | Immune response | Small cell lung carcinoma | Tumor-infiltrating lymphocytes | Melanoma | Lung carcinoma | Gene expression | Ribonucleic acid--RNA | Patients | CD4 antigen | Immune systems | Immune checkpoint | Reproducibility | PD-L1 protein | Biomarkers | Head and neck cancer | Interferon | Solid tumors | Cancer | Tumors | Index Medicus
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 4, pp. e10312 - e10312
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 75, Issue 3, pp. 677 - 682
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2009, Volume 27, Issue 12, pp. 2030 - 2037
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2013, Volume 19, Issue 23, pp. 6556 - 6565
Journal Article
Antioxidants & Redox Signaling, ISSN 1523-0864, 09/2013, Volume 19, Issue 7, pp. 644 - 660
Journal Article